Multiple sclerosis biotech firm TG Therapeutics (TGTX) is Thursday’s pick for IBD 50 Growth Stocks To Watch. TGTX stock jumped Thursday and broke out of an irregular base and is in a buy zone. Shares of TG Therapeutics bolted higher after the company topped fourth-quarter sales expectations with in-line earnings Monday. The IBD 50 and IBD Leaderboard component makes a…
